Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease Journal Articles Refereed uri icon

Overview

Published in

  • Journal of Clinical Oncology

Time

Date/time value

  • 2012

Identity

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.34.7898

Additional Document Info

Parent Title

  • Journal of Clinical Oncology

Volume

  • 30

Issue

  • 5

Publisher

  • American Society of Clinical Oncology